跳至主要内容
临床试验/ITMCTR1900002318
ITMCTR1900002318招募中未知

Multicenter randomized controlled clinical trial for therapeutic Evaluation of TCM in patients with extensive small cell lung cancer (SCLC)

Beijing Hospital of TCM, Capital Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) patients diagnosed with small cell lung cancer by cytology or histology with distant organ metastasis and/or lymph node metastasis of the contralateral hilar lung in extensive stage (via cranial MRI, chest CT, bone scan, abdominal CT or PET/CT);
  • (2) did not receive radiotherapy, chemotherapy or surgical treatment, with evaluable lesions;
  • (3) ECOG score 2, and the expected survival time is > for 3 months;
  • (4) aged 18-75 years, with serious diseases of heart, brain, kidney, liver, blood and other systems;
  • (5) agree to participate in this study and sign the informed consent.

排除标准

  • (1) massive pleural or peritoneal effusion or pericardial effusion causes dyspnea;
  • (2) symptomatic bone metastases requiring radiotherapy;
  • (3) brain metastasis;
  • (4) pregnant or lactating women, or serious diseases of heart, lung, liver, kidney, blood and other systems;
  • (5) patients who are known to be allergic to the study drugs;
  • (6) patients undergoing other drug trials.

研究者

发起方
Beijing Hospital of TCM, Capital Medical University

相似试验